EETs promote hypoxic pulmonary vasoconstriction via constrictor prostanoids
- 1 August 2017
- journal article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 313 (2) , L350-L359
Abstract
To test the hypothesis that epoxyeicosatrienoic acids (EETs) facilitate pulmonary responses to hypoxia, male wild-type (WT) and soluble-epoxide hydrolase knockout (sEH-KO) mice, and WT mice chronically fed a sEH inhibitor ( t-TUCB; 1 mg·kg−1·day−1) were used. Right ventricular systolic pressure (RVSP) was recorded under control and hypoxic conditions. The control RVSP was comparable among all groups. However, hypoxia elicited increases in RVSP in all groups with predominance in sEH-KO and t-TUCB-treated mice. 14,15-EEZE (an EET antagonist) attenuated the hypoxia-induced greater elevation of RVSP in sEH-deficient mice, suggesting an EET-mediated increment. Exogenous 5,6-; 8,9-, or 14,15-EET (0.05 ng/g body wt) did not change RVSP in any conditions, but 11,12-EET enhanced RVSP under hypoxia. Isometric tension was recorded from pulmonary arteries isolated from WT and sEH-KO mice, vessels that behaved identically in their responsiveness to vasoactive agents and vessel stretch. Hypoxic pulmonary vasoconstriction (HPV, expressed as increases in hypoxic force) was significantly greater in vessels of sEH-KO than WT vessels; the enhanced component was inhibited by EEZE. Treatment of WT vessels with 11,12-EET enhanced HPV to the same level as sEH-KO vessels, confirming EETs as primary players. Inhibition of cyclooxygenases (COXs) significantly enhanced HPV in WT vessels, but attenuated HPV in sEH-KO vessels. Blocking/inhibiting COX-1, prostaglandin H2 (PGH2)/thromboxane A2 (TXA2) receptors and TXA synthase prevented the enhanced HPV in sEH-KO vessels but had no effects on WT vessels. In conclusion, an EET-dependent alteration in PG metabolism that favors the action of vasoconstrictor PGH2 and TXA2 potentiates HPV and hypoxia-induced elevation of RVSP in sEH-deficient mice.Keywords
Funding Information
- HHS | NIH | National Heart, Lung, and Blood Institute (NHBLI) (HL129797, HL070653, HL115124)
- HHS | NIH | National Institute of Environmental Health Sciences (NIEHS) (ES02710, ES04699)
This publication has 47 references indexed in Scilit:
- 11,12-EET Stimulates the Association of BK Channel α and β1 Subunits in Mitochondria to Induce Pulmonary VasoconstrictionPLOS ONE, 2012
- Role of Lipoxygenase Metabolites of Arachidonic Acid in Enhanced Pulmonary Artery Contractions of Female RabbitsHypertension, 2011
- Hypoxia-induced pulmonary hypertension: comparison of soluble epoxide hydrolase deletion vs. inhibitionCardiovascular Research, 2009
- Epoxyeicosatrienoic acids and the soluble epoxide hydrolase are determinants of pulmonary artery pressure and the acute hypoxic pulmonary vasoconstrictor responseThe FASEB Journal, 2008
- Cytochrome P450 Epoxygenase Gene Function in Hypoxic Pulmonary Vasoconstriction and Pulmonary Vascular RemodelingHypertension, 2006
- Vasoactive prostanoids are generated from arachidonic acid by COX-1 and COX-2 in the mouseAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- NOS3 deficiency augments hypoxic pulmonary vasoconstriction and enhances systemic oxygenation during one-lung ventilation in miceJournal of Applied Physiology, 2005
- Endothelium-derived nitric oxide regulates systemic and pulmonary vascular resistance during acute hypoxia in humansJACC, 1996
- Role of Endothelium-Derived Metabolites of Arachidonic Acid in Enhanced Pulmonary Artery Contractions in Female RabbitsHypertension, 1996
- Endothelial dysfunction augments myogenic arteriolar constriction in hypertension.Hypertension, 1993